EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma

Lara Ravanetti, Tamara Dekker, Lihui Guo, Annemiek Dijkhuis, Barbara S Dierdorp, Zuzana Diamant, Sandrine Florquin, René Lutter

Allergy · 2023-02 · 78 (2) · 559-562

DOI: 10.1111/all.15513 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Allergy, online erschienen am 18.09.2022. Verfasst von Lara Ravanetti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The…. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 12, Asthma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 12AsthmaHumansAnimalsMiceLungSulfur CompoundsTissue Inhibitor of Metalloproteinase-1

Substanzen

FP-025Matrix Metalloproteinase 12Sulfur CompoundsTissue Inhibitor of Metalloproteinase-1

Autor:innen und Institutionen

  • Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
  • Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
  • Department of Pathology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.

Zitieren

APA

Ravanetti, L., Dekker, T., Guo, L., Dijkhuis, A., Dierdorp, B. S., Diamant, Z., Florquin, S., & Lutter, R. (2023). Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma. Allergy, 78(2), 559-562. https://doi.org/10.1111/all.15513

Vancouver

Ravanetti L, Dekker T, Guo L, Dijkhuis A, Dierdorp BS, Diamant Z, et al. Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma. Allergy. 2023;78(2):559-562. doi:10.1111/all.15513

BibTeX
@article{Ravanetti2023,
  author = {Ravanetti, Lara and Dekker, Tamara and Guo, Lihui and Dijkhuis, Annemiek and Dierdorp, Barbara S and Diamant, Zuzana and Florquin, Sandrine and Lutter, René},
  title = {Efficacy of FP ‐025: A novel matrix metalloproteinase‐12 ( MMP ‐12) inhibitor in murine allergic asthma},
  journal = {Allergy},
  year = {2023},
  volume = {78},
  number = {2},
  pages = {559--562},
  doi = {10.1111/all.15513}
}
Kostenlos starten →